Collaborations
Mike Murphy, FMedSci
MRC Mitochondrial Biology Unit & Department of Medicine, University of Cambridge, UK
http://www.mrc-mbu.cam.ac.uk/people/mike-murphy
Mitochondrial Therapies Group (MTG)
MTG brings together chemists, biochemists and clinicians to enable rational design, synthesis and testing of novel diagnostic and therapeutic compounds that target mitochondria.
https://www.mitotherapy.co.uk
BHF Cambridge Centre for Cardiovascular Research Excellence
Antonio Vidal-Puig MD PhD FRCP FMedSci EMBA
MRC Metabolic Disease Unit, University of Cambridge, UK
Sanger Institute
http://www.tvplab-cambridge.com
http://www.sanger.ac.uk/people/directory/vidal-puig-antonio
Zhelong Xu
Tianjin Medical University, China
James Downey
Univsersity of South Alabama, USA
Mike Murphy, FMedSci
MRC Mitochondrial Biology Unit & Department of Medicine, University of Cambridge, UK
http://www.mrc-mbu.cam.ac.uk/people/mike-murphy
Mitochondrial Therapies Group (MTG)
MTG brings together chemists, biochemists and clinicians to enable rational design, synthesis and testing of novel diagnostic and therapeutic compounds that target mitochondria.
https://www.mitotherapy.co.uk
BHF Cambridge Centre for Cardiovascular Research Excellence
Antonio Vidal-Puig MD PhD FRCP FMedSci EMBA
MRC Metabolic Disease Unit, University of Cambridge, UK
Sanger Institute
http://www.tvplab-cambridge.com
http://www.sanger.ac.uk/people/directory/vidal-puig-antonio
Zhelong Xu
Tianjin Medical University, China
James Downey
Univsersity of South Alabama, USA